# | Title | Journal | Year | Citations |
---|
1 | Diagnostic accuracy of the vegetative and minimally conscious state: Clinical consensus versus standardized neurobehavioral assessment | BMC Neurology | 2009 | 957 |
2 | Post-stroke infection: A systematic review and meta-analysis | BMC Neurology | 2011 | 555 |
3 | Characteristics of compounds that cross the blood-brain barrier | BMC Neurology | 2009 | 520 |
4 | Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis | BMC Neurology | 2013 | 520 |
5 | A systematic review of population based epidemiological studies in Myasthenia Gravis | BMC Neurology | 2010 | 488 |
6 | Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study | BMC Neurology | 2011 | 457 |
7 | The Cambridge Centre for Ageing and Neuroscience (Cam-CAN) study protocol: a cross-sectional, lifespan, multidisciplinary examination of healthy cognitive ageing | BMC Neurology | 2014 | 430 |
8 | Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis | BMC Neurology | 2014 | 429 |
9 | COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord | BMC Neurology | 2006 | 420 |
10 | Incidence and prevalence of multiple sclerosis in Europe: a systematic review | BMC Neurology | 2013 | 392 |
11 | Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome | BMC Neurology | 2004 | 389 |
12 | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation | BMC Neurology | 2012 | 275 |
13 | The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study | BMC Neurology | 2005 | 271 |
14 | Evidence based guidelines for complex regional pain syndrome type 1 | BMC Neurology | 2010 | 256 |
15 | Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials | BMC Neurology | 2008 | 242 |
16 | Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy | BMC Neurology | 2007 | 241 |
17 | Pesticide exposure and risk of Parkinson's disease: A family-based case-control study | BMC Neurology | 2008 | 221 |
18 | Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis | BMC Neurology | 2016 | 221 |
19 | Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379] | BMC Neurology | 2004 | 208 |
20 | Open-label add-on treatment trial of minocycline in fragile X syndrome | BMC Neurology | 2010 | 197 |
21 | APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway | BMC Neurology | 2008 | 196 |
22 | Association of childhood trauma with cognitive function in healthy adults: a pilot study | BMC Neurology | 2010 | 193 |
23 | Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome | BMC Neurology | 2004 | 184 |
24 | Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment | BMC Neurology | 2002 | 183 |
25 | Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations | BMC Neurology | 2017 | 183 |
26 | Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain | BMC Neurology | 2009 | 178 |
27 | Protocol for the Locomotor Experience Applied Post-stroke (LEAPS) trial: a randomized controlled trial | BMC Neurology | 2007 | 176 |
28 | Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial | BMC Neurology | 2012 | 176 |
29 | Early intervention in Alzheimer’s disease: a health economic study of the effects of diagnostic timing | BMC Neurology | 2014 | 174 |
30 | Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans | BMC Neurology | 2013 | 171 |
31 | Meningeal and cortical grey matter pathology in multiple sclerosis | BMC Neurology | 2012 | 160 |
32 | The association between cognitive function and white matter lesion location in older adults: a systematic review | BMC Neurology | 2012 | 159 |
33 | Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study | BMC Neurology | 2015 | 159 |
34 | Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial | BMC Neurology | 2008 | 157 |
35 | Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol | BMC Neurology | 2011 | 154 |
36 | Reperfusion therapy in acute ischemic stroke: dawn of a new era? | BMC Neurology | 2018 | 154 |
37 | Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review | BMC Neurology | 2009 | 150 |
38 | Reproducibility and accuracy of optic nerve sheath diameter assessment using ultrasound compared to magnetic resonance imaging | BMC Neurology | 2013 | 149 |
39 | Mindfulness based interventions in multiple sclerosis - a systematic review | BMC Neurology | 2014 | 148 |
40 | Are mild head injuries as mild as we think? Neurobehavioral concomitants of chronic post-concussion syndrome | BMC Neurology | 2006 | 147 |
41 | Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study | BMC Neurology | 2010 | 146 |
42 | Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden | BMC Neurology | 2012 | 146 |
43 | Pilot study of locomotion improvement using hybrid assistive limb in chronic stroke patients | BMC Neurology | 2013 | 144 |
44 | Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats | BMC Neurology | 2004 | 142 |
45 | Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy | BMC Neurology | 2017 | 142 |
46 | Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis | BMC Neurology | 2006 | 141 |
47 | Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer’s disease-relevant murine model | BMC Neurology | 2015 | 141 |
48 | Corticosteroid and antiviral therapy for Bell's palsy: A network meta-analysis | BMC Neurology | 2011 | 137 |
49 | A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort | BMC Neurology | 2014 | 137 |
50 | Pediatric multiple sclerosis: a review | BMC Neurology | 2018 | 137 |